Europe’s personalised medicine sector boosted by Sino-EU PerMed project

The Sino-EU PerMed project, launched in January 2020, is a bi-regional consortium of six partners from governmental, funding and research organisations to promote personalised medicine cooperation between Europe and China.

Supporter

Content-Type:

Sponsored By An organization or individual has paid to be connected to this work but did not approve or review it.

Sino-EU cooperation can accelerate the improvement of the quality of care provided by governments and promote well-being. [Shutterstock / Marcin Janiec]

Euractiv's Advocacy Lab 24-06-2024 09:58 1 min. read Content type: Sponsored By Euractiv is part of the Trust Project

The Sino-EU PerMed project, launched in January 2020, is a bi-regional consortium of six partners from governmental, funding and research organisations to promote personalised medicine cooperation between Europe and China.

The project was set up as part of a concerted larger effort by the European Commission to increase international collaboration to promote personalised medicine and was devised to engage China in the International Consortium on Personalised Medicine [ICPerMed] - an EU Member States driven initiative and advance the implementation of the Strategic Research and Innovation Agenda on personalised medicine.

This Euractiv report explains the purpose of the project, what it set out to achieve, and the expected outcomes.

Health

As China-EU personalised medicines partnership comes to an end, what comes next?

01/07/2024

3 min. read

Health

Sino-EU personalised medicine project, Europe bridging a data divide

23/06/2024

7 min. read

Health

Promoted content

Europe-China cooperation in personalised medicine: paving the way for a scientific common path

10/07/2024

3 min. read

Subscribe to our newsletters

Subscribe